Company / R&D per Share
AtriCure, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.03
FY2025
5-year range
$1.07 / $2.03
FY2021-FY2025
Trend
+0.3%
vs FY2024
Sector context
#46 of 103
Health Care
What the data says
At $2.03, AtriCure, Inc.'s r&d per share ranks #46 of 103 in the Health Care sector. R&D per Share has increased for 4 consecutive years, from $1.07 in FY2021 to $2.03 in FY2025.
Based on SEC 10-K filings.
2.03 in FY2025 with a 5-year CAGR of +13.3%.
Improved from $1.59 to $2.03 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +17.7%
- 5-Year CAGR
- +13.3%
- 10-Year CAGR
- -
Sector benchmark
#46 of 103 in Health CareTop 45% of 103This company $2.03 Sector average $2.13
▼
-4.8% below sector average
Key checks
Key Insights
- AtriCure, Inc.'s r&d per share has grown for 4 consecutive years.
- In FY2025, r&d per share increased 0.3% year-over-year.
- Ranks #46 out of 103 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2018.
Company context
Key Data Points
- Negative profit margin: -9.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.03 | +0.3% |
| FY2024 | $2.02 | +27.5% |
| FY2023 | $1.59 | +27.4% |
| FY2022 | $1.25 | +16.5% |
| FY2021 | $1.07 | -1.5% |
| FY2020 | $1.09 | +1.7% |
| FY2019 | $1.07 | +6.4% |
| FY2018 | $1.00 | -2.0% |
| FY2017 | $1.02 | -7.7% |
| FY2016 | $1.11 | +18.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026